SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-045528
Filing Date
2007-03-02
Accepted
2007-03-02 17:10:56
Documents
6
Period of Report
2007-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 34099
2 FORM OF CHANGE-IN-CONTROL AGREEMENT EMPLOYED ON OR BEFORE FEBRUARY 28, 2007 dex991.htm EX-99.1 79556
3 FORM OF CHANGE-IN-CONTROL AGREEMENT EMPLOYED AFTER FEBRUARY 28, 2007 dex992.htm EX-99.2 78248
4 FORM OF AMENDED AND RESTATED CHANGE-IN-CONTROL AGREEMENT FOR THE CEO dex993.htm EX-99.3 78749
5 NOTICE OF GRANT dex994.htm EX-99.4 20146
6 PERFORMANCE SHARE AGREEMENT dex995.htm EX-99.5 26909
  Complete submission text file 0001193125-07-045528.txt   319329
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25317 | Film No.: 07668725
SIC: 2836 Biological Products, (No Diagnostic Substances)